BrainStorm Granted Patent For Stem Cell Treatment

BrainStorm Cell Therapeutics, an Israeli developer of adult stem cell technologies for neurodegenerative diseases, has been granted a patent by the Israeli Patent Office for the company’s NurOwn Technology Platform. Founded in 2004 and now led by Chaim Lebovits, BrainStorm is developing treatments for Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig’s disease), Multiple Sclerosis (MS) and Parkinson’s Disease (PD).